Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buturovic-Ponikvar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buturovic-Ponikvar, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: V53-V55
© 2003 European Renal Association-European Dialysis and Transplant Association

Renal replacement therapy in Slovenia: annual report 2001

Jadranka Buturovic-Ponikvar on behalf of the Expert Group for Dialysis in Slovenia at the Ministry of Health, Republic of Slovenia

The Expert Group for Dialysis in Slovenia at the Ministry of Health, Republic of Slovenia comprises the following: President: Rafael Ponikvar (Ljubljana), Members: Tone Adamlje (Trbovlje), Danica Blanusa (Ptuj), Sonja Cimerman Steklasa (Novo Mesto), Andrej Gucek (Ljubljana), Aljosa Kandus (Ljubljana), Sonja Kapun (Krsko), Marjeta Lesnik (Celje), Marko Malovrh (Ljubljana), Marjan Mocivnik (Zrece), Gregor Novljan (Ljubljana), Nikola Rukavina (Ljubljana), Karel Pecovnik (Maribor), Igor Rus (Jesenice), Martin Sinigoj (Sempeter), Franc Stivan (Murska Sobota), Bojan Vujkovac (Slovenj Gradec), Sasa Zuzek Resek (Izola).

The total number of end-stage renal failure patients treated by renal replacement therapy increased, from 1435 at 31 December 2000 to 1542 at 31 December 2001 (7.5% increase). At the end of 2001, 771 p.m.p. end-stage renal failure patients were treated by renal replacement therapy in Slovenia, 73% of them with haemodialysis, 7.4% with peritoneal dialysis and 19.7% had a functioning graft. Incident (new) patients in 2001 were 144 p.m.p. The number of haemodialysis patients increased by 7% compared with the year before, the number of patients on peritoneal dialysis decreased by 3.4% and the number of patients with a functioning graft increased by 13.9%. The gross mortality rate of dialysis patients was stable between the years and was 10.4% in 2001. Erythropoietin therapy was prescribed to 87.3% of dialysis patients (88.9% of haemodialysis patients and 71.7% of patients on peritoneal dialysis). The number of dialysis patients positive for hepatitis B or hepatitis C virus is relatively low, 3.2% of all dialysis patients; an increased number of MRSA-positive dialysis patients is observed in 2001 (2.9% of all dialysis patients). The epidemiology of renal replacement therapy in Slovenia is in general comparable with that of the countries of the European Union.

Keywords: dialysis; end-stage renal disease; kidney transplantation; renal replacement therapy

Correspondence and offprint requests to: Professor Dr Jadranka Buturovic-Ponikvar, Department of Nephrology, University Medical Center Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia. E-mail: jadranka.buturovic{at}mf.uni-lj.si


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.